These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 29893702)

  • 1. Racial, Ethnic, and Age Disparities in Incidence and Survival of Intrahepatic Cholangiocarcinoma in the United States; 1995-2014.
    Antwi SO; Mousa OY; Patel T
    Ann Hepatol; 2018 July - August ,; 17(4):604-614. PubMed ID: 29893702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States.
    Patel T
    Hepatology; 2001 Jun; 33(6):1353-7. PubMed ID: 11391522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial and ethnic variations in the epidemiology of intrahepatic cholangiocarcinoma in the United States.
    McLean L; Patel T
    Liver Int; 2006 Nov; 26(9):1047-53. PubMed ID: 17032404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Clinical Features and Outcomes Between Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in the United States.
    Lee YT; Wang JJ; Luu M; Noureddin M; Nissen NN; Patel TC; Roberts LR; Singal AG; Gores GJ; Yang JD
    Hepatology; 2021 Nov; 74(5):2622-2632. PubMed ID: 34114675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017.
    Javle M; Lee S; Azad NS; Borad MJ; Kate Kelley R; Sivaraman S; Teschemaker A; Chopra I; Janjan N; Parasuraman S; Bekaii-Saab TS
    Oncologist; 2022 Oct; 27(10):874-883. PubMed ID: 35972334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of Cholangiocarcinoma; United States Incidence and Mortality Trends.
    Gad MM; Saad AM; Faisaluddin M; Gaman MA; Ruhban IA; Jazieh KA; Al-Husseini MJ; Simons-Linares CR; Sonbol MB; Estfan BN
    Clin Res Hepatol Gastroenterol; 2020 Nov; 44(6):885-893. PubMed ID: 32359831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of metastasis and survival between extrahepatic and intrahepatic cholangiocarcinoma: A large population-based study.
    Liao P; Cao L; Chen H; Pang SZ
    Medicine (Baltimore); 2021 Apr; 100(16):e25635. PubMed ID: 33879742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial and Ethnic Disparities in the Incidence of Pediatric Extracranial Embryonal Tumors.
    Friedrich P; Itriago E; Rodriguez-Galindo C; Ribeiro K
    J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 29117360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased risk for colorectal cancer under age 50 in racial and ethnic minorities living in the United States.
    Rahman R; Schmaltz C; Jackson CS; Simoes EJ; Jackson-Thompson J; Ibdah JA
    Cancer Med; 2015 Dec; 4(12):1863-70. PubMed ID: 26471963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers: Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010.
    Zeng C; Wen W; Morgans AK; Pao W; Shu XO; Zheng W
    JAMA Oncol; 2015 Apr; 1(1):88-96. PubMed ID: 26182310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholangiocarcinoma in Germany: Epidemiologic trends and impact of misclassification.
    Walter D; Ferstl P; Waidmann O; Trojan J; Hartmann S; Schnitzbauer AA; Zeuzem S; Kraywinkel K
    Liver Int; 2019 Feb; 39(2):316-323. PubMed ID: 30176117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced Intrahepatic Cholangiocarcinoma: Post Hoc Analysis of the ABC-01, -02, and -03 Clinical Trials.
    Lamarca A; Ross P; Wasan HS; Hubner RA; McNamara MG; Lopes A; Manoharan P; Palmer D; Bridgewater J; Valle JW
    J Natl Cancer Inst; 2020 Feb; 112(2):200-210. PubMed ID: 31077311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival and Causes of Death among Patients with Intrahepatic Cholangiocarcinoma in the United States from 2000 to 2018.
    Elgenidy A; Afifi AM; Jalal PK
    Cancer Epidemiol Biomarkers Prev; 2022 Dec; 31(12):2169-2176. PubMed ID: 36099432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the AJCC 8th Edition Staging System for Pathologically Versus Clinically Staged Intrahepatic Cholangiocarcinoma (iCCA): a Time to Revisit a Dogma? A Surveillance, Epidemiology, and End Results (SEER) Analysis.
    Kamarajah SK
    J Gastrointest Cancer; 2019 Sep; 50(3):392-399. PubMed ID: 29512000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival differences in nasopharyngeal carcinoma among racial and ethnic minority groups in the United States: A retrospective cohort study.
    Challapalli SD; Simpson MC; Adjei Boakye E; Walker RJ; Antisdel JL; Ward GM; Osazuwa-Peters N
    Clin Otolaryngol; 2019 Jan; 44(1):14-20. PubMed ID: 30216675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biliary tract cancer incidence and trends in the United States by demographic group, 1999-2013.
    Van Dyke AL; Shiels MS; Jones GS; Pfeiffer RM; Petrick JL; Beebe-Dimmer JL; Koshiol J
    Cancer; 2019 May; 125(9):1489-1498. PubMed ID: 30645774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival after surgery among patients with cholangiocarcinoma in Northeast Thailand according to anatomical and morphological classification.
    Tawarungruang C; Khuntikeo N; Chamadol N; Laopaiboon V; Thuanman J; Thinkhamrop K; Kelly M; Thinkhamrop B
    BMC Cancer; 2021 May; 21(1):497. PubMed ID: 33941120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancer incidence in the United States, 1999-2004 : an updated analysis of data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program.
    Rim SH; Seeff L; Ahmed F; King JB; Coughlin SS
    Cancer; 2009 May; 115(9):1967-76. PubMed ID: 19235249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disparities in curative treatments and outcomes for early stage intrahepatic cholangiocarcinoma in the United States.
    Lee YT; Singal AG; Lauzon M; Agopian VG; Luu M; Noureddin M; Todo T; Kim IK; Friedman ML; Kosari K; Nissen NN; Roberts LR; Heimbach JK; Gores GJ; Yang JD
    Cancer; 2022 Oct; 128(20):3610-3619. PubMed ID: 35997126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple myeloma incidence, mortality, and survival differences at the intersection of sex, age, and race/ethnicity: A comparison between Puerto Rico and the United States SEER population.
    Castañeda-Avila MA; Suárez-Ramos T; Torres-Cintrón CR; Epstein MM; Gierbolini-Bermúdez A; Tortolero-Luna G; Ortiz-Ortiz KJ
    Cancer Epidemiol; 2024 Apr; 89():102537. PubMed ID: 38295555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.